-
Aegis Sciences Launches New Medication Adherence Tool for Behavioral Healthcare
AcuRiseID™ is a new urinalysis that monitors medication adherence in people with mental illness and substance abuse disorder Nashville, Tennessee (Sept.…
AcuRiseID™ is a new urinalysis that monitors medication adherence in people with mental illness and substance abuse disorder Nashville, Tennessee (Sept. 12, 2018) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative testing and consulting services to providers, today launched AcuRiseID™, a new tool that offers accurate and informative medication monitoring…
-
Kara Allen named Fellow of the American Chemical Society
Aegis Sciences director honored for career achievements
Aegis Sciences director honored for career achievements
-
Aegis Sciences Corporation announces laboratory expansion open house
Nashville, TN – July 24, 2018 - Aegis Sciences Corporation, a national leader in healthcare and forensic laboratory sciences, is expanding! Wednesday,…
Nashville, TN – July 24, 2018 - Aegis Sciences Corporation, a national leader in healthcare and forensic laboratory sciences, is expanding! Wednesday, August 1st, 2018501 Great Circle Road (parking behind building)6:00 p.m. to 8:00 p.m. Meet with our recruiters and laboratory leaders to learn about our recent growth, exciting new opportunities, and competitive benefits package. We are seeking new…
-
Aegis Sciences Rebrands Drug Interaction Test to InterACT Rx
InterACT RxTM testing detects over 120 substances known to cause adverse drug interactions.Nashville, Tenn. (July 12, 2018) – Aegis Sciences Corporation,…
InterACT RxTM testing detects over 120 substances known to cause adverse drug interactions.Nashville, Tenn. (July 12, 2018) – Aegis Sciences Corporation, a leading healthcare company that provides information to clinicians to help them make better decisions through medication adherence testing, is pleased to announce InterACT RxTM as the name for its Drug-Drug Interaction (DDI) testing. “The new name…
-
Dr. Elaine Jeter Joins Aegis Sciences Corporation as Senior Medical Policy Advisor
Nashville, TN – April 24, 2018 - Aegis Sciences Corporation, a leading healthcare sciences and forensic toxicology laboratory, is pleased to announce that…
Nashville, TN – April 24, 2018 - Aegis Sciences Corporation, a leading healthcare sciences and forensic toxicology laboratory, is pleased to announce that Dr. Elaine Jeter has joined the company as its Senior Medical Policy Advisor. “I am delighted to welcome Dr. Elaine Jeter to Aegis,” said Dr. Frank Basile, Aegis’s Chief Executive Officer. “Dr. Jeter’s wealth of knowledge and experience in clinical…
-
Dr. Elaine Jeter Joins Aegis Sciences Corporation as Senior Medical Policy Advisor
Nashville, TN – April 24, 2018 - Aegis Sciences Corporation, a leading healthcare sciences and forensic toxicology laboratory, is pleased to announce that…
Nashville, TN – April 24, 2018 - Aegis Sciences Corporation, a leading healthcare sciences and forensic toxicology laboratory, is pleased to announce that Dr. Elaine Jeter has joined the company as its Senior Medical Policy Advisor. “I am delighted to welcome Dr. Elaine Jeter to Aegis,” said Dr. Frank Basile, Aegis’s Chief Executive Officer. “Dr. Jeter’s wealth of knowledge and experience in clinical…
-
People Are So Bad With Blood Pressure Meds, There's Now A Drug Test To Keep Them Honest
By BLAKE FARMER A Nashville company has developed a drug test to make hypertension patients a little more honest about taking their blood pressure medication.…
By BLAKE FARMER A Nashville company has developed a drug test to make hypertension patients a little more honest about taking their blood pressure medication. The screening developed by Aegis Sciences is meant to spark a candid conversation about whether someone is sticking with their prescription, because many don't... Read full article from Nashville Public Radio.
-
Aegis Sciences Corporation launches KardiAssure
KardiAssure provides doctors with clinical insight to improve patient outcomes and address non-adherence of more than 50 cardiovascular medications
KardiAssure provides doctors with clinical insight to improve patient outcomes and address non-adherence of more than 50 cardiovascular medications
-
Tim Ryan Joins Aegis Sciences Corporation as Chief Information Officer
Nashville, TN – November 3, 2017 – Aegis Sciences Corporation, a leading healthcare sciences and forensic toxicology laboratory, is pleased to announce…
Nashville, TN – November 3, 2017 – Aegis Sciences Corporation, a leading healthcare sciences and forensic toxicology laboratory, is pleased to announce that Tim Ryan has joined the company as Chief Information Officer. Tim brings more than 30 years of experience in information technology. “I am delighted to welcome Tim Ryan to Aegis,” said Dr. Frank Basile, Aegis’s Chief Executive Officer. “Tim’s…
-
Aegis Data on Sports Drug Testing: Frequent Testing Deters Usage Among Student Athletes
Over the years, Aegis has crafted or reviewed many substance abuse policies and has found that each and every policy is defined as a deterrent program.…
Over the years, Aegis has crafted or reviewed many substance abuse policies and has found that each and every policy is defined as a deterrent program. How each institution or organization achieves this goal varies, but the data unequivocally suggests that the frequency of drug testing correlates with deterrence. In 2015, about 1 in 5 young adults aged 18 to 25 (19.8 percent) were current users of…
